Actionable news
All posts from Actionable news
Actionable news in DVAX: Dynavax Technologies Corporation,

William Blair Boosts Price Target for Dynavax Technologies Corporation (DVAX) as VRBPAC Panel Gives Thumbs Up to Heplisav

William Blair analyst Y Katherine Xu is out with a bullish note on shares of Dynavax Technologies Corporation (NASDAQ:DVAX), after the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) panel voted 12-1 with 3 abstentions that the safety to date supports DVAX’s Heplisav approval for vaccination against hepatitis B infection in adults over 18 years old.

The analyst wrote, “With the overwhelmingly positive note, the panel also focused on how to design and ensure proper and timely execution of the...